Market Newsdesk

NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP, a nationally recognized securities litigation law firm, reminds investors that a securities fraud class action lawsuit has been filed against Microvast Holdings, Inc. (NASDAQ : MVST) (“Microvast” or the “Company”), on behalf of those who purchased or acquired Microvast common stock between April 1, 2025 and March 16, 2026, inclusive.

PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION

Investors who purchased Microvast shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for September 21, 2026.

The filed complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:

• due to, inter alia, inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, Defendants had overstated Microvast’s ability to reach its margin targets;
• Defendants overstated Microvast’s ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and
• as a result, Defendants’ public statements were materially false and misleading at all relevant times.

The market received its first hint of the true state of Microvast’s business and operations on June 25, 2025, when the short seller, Grizzly Research, issued a report concerning Microvast (the “Grizzly Report”), alleging that the Company “is fabricating a significant part of its business and capabilities”, including, inter alia, by overstating the level of activity at its production facilities, including the Huzhou facility, and likewise overstating the prospective economic opportunities from its commercial partnerships.

Following publication of the Grizzly Report, Microvast’s stock price plunged during intraday trading, falling as much as $0.40 per share, or approximately 10.23%, before ultimately closing at $3.90 per share. Then, barely one month after the Grizzly Report, on August 1, 2025, Microvast announced the departure of its Chief Financial Officer, Charles Schultz, just three months after he joined the Company. On this news, Microvast’s stock price fell $0.30 per share, or approximately 9.93%, to close at $2.72 per share on August 4, 2025.

Subsequently, operating results for the quarter ended September 30, 2025, in which it revealed that production following the Huzhou Phase 3.2 expansion would not begin until Q1 2026 – after repeatedly advising investors that the additional capacity associated with the expansion would be online by Q4 2025. On this news, Microvast’s stock price fell $0.50 per share, or approximately 10%, to close at $4.48 per share on November 11, 2025.

Finally, on March 16, 2026, Microvast issued a press release reporting its financial and operating results for the quarter and year ended December 31, 2025. Among other items, Microvast reported that gross margin declined to approximately 1% for the quarter, down sharply from approximately 36% for the same period in the prior year, which the Company attributed to inventory impairment charges arising from “specialized ESS components”. Microvast also reported revenue of $96.5 million for the quarter, representing a 15% year-over-year decrease and falling well short of the consensus estimate of $136.4 million. Microvast attributed this result to “regulatory shifts in South Korea and delays in customer platform ramp-up” in Europe, the Middle East, and Africa.

On this news, Microvast’s stock price fell $0.79 per share, or 34.2%, to close at $1.52 per share on March 17, 2026.

WHY WOLF HALDENSTEIN?

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

There is no cost or obligation to speak with an attorney.

Contact:

• Phone: (800) 575-0735 or (212) 545-4774
• Email: 
  [email protected]
• Contact Person: Gregory Stone, Director of Case and Financial Analysis

Firm Website:
 Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Lead Plaintiff Deadline September 14, 2026

NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP, a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against GPGI, Inc. (“GPGI”) (NYSE: GPGI), on behalf of those who purchased or acquired GPGI Class A common stock between November 3, 2025 and May 6, 2026, inclusive.

PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION

Investors who purchased GPGI shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for September 14, 2026.

Main Allegations:

The filed complaint alleges that GPGI made materially false statements regarding:

1. Overstating the value of Husky Technologies Limited (“Husky”) (acquired in January 2026)
2. Husky failing to meet projected revenue and EBITDA targets
3. The acquisition being primarily motivated to generate fees for Resolute Holdings (“Resolute”) rather than create shareholder value
4. Defendants’ statements lacking reasonable factual basis

Stock Performance Decline:

• March 12, 2026: After Q4 2025 results showing EBITDA decline, stock dropped 16.4% ($3.23/share)
• May 7, 2026: After Q1 2026 results showing further deterioration and guidance cuts, stock dropped 25.9% ($4.52/share)

Timeline Context:

• August 2024: Resolute acquisition announced
• January 2026: Husky acquisition completed
• February 2026: Negative research report published
• March-May 2026: Stock decline events

WHY WOLF HALDENSTEIN?

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

There is no cost or obligation to speak with an attorney.

Contact:

• Phone: (800) 575-0735 or (212) 545-4774
• Email: 
  [email protected]
• Contact Person: Gregory Stone, Director of Case and Financial Analysis

Firm Website:
 Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Assets in the Fund have doubled since April, with the $200 million milestone arriving less than two weeks after JEDI announced it was the first ETF with indirect exposure to Shield AI, the privately held autonomy company behind the Hivemind AI pilot and the V-BAT aircraft.

MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) — Defiance ETFs today announced that the Defiance Drone & Modern Warfare ETF (NYSE: JEDI) has surpassed $200 million in assets under management as of August 21, 2026, less than eleven months after the Fund’s September 25, 2025 launch. The milestone comes less than two weeks after Defiance announced that JEDI had become the first ETF to provide indirect exposure to Shield AI (SHAI.PVT), the privately held defense autonomy company, through an interest in a single-asset special purpose vehicle.

Accelerating Adoption

JEDI
crossed $100 million in assets on April 20, 2026, less than seven months after launch. Four months later, those assets have doubled. The mandate has grown along with them. A supplement to the Fund’s prospectus dated July 27, 2026 added a secondary investment objective: with respect to up to 15% of the Fund’s net assets, from time to time and at the Adviser’s discretion, the Fund seeks to provide exposure to companies that would have qualified for inclusion in the BITA Drone & Modern Warfare Select Index except that their securities are not publicly traded. On August 11, 2026, Defiance announced that JEDI had put that mandate to work, bringing Shield AI exposure into the portfolio.

JEDI targets the companies rebuilding modern defense around drones, autonomous systems, and AI-driven capabilities across land, sea, air, and space. All of it sits in an ETF structure, with full holdings published daily and shares tradable throughout the trading day.

“Crossing $200 million in under a year tells us the thesis is landing,” said Sylvia Jablonski, Chief Investment Officer of Defiance ETFs. “Modern warfare is undergoing a paradigm shift around drones, autonomy, and software, and investors increasingly want that entire stack in a single ticker. Bringing Shield AI into the fund was about completing that picture, because the companies defining this category are not all public yet. Shareholders should not have to wait for an IPO to hold one of the companies at the forefront of autonomy in defense, and this milestone tells us they agree.”

The Shield AI Exposure

The Fund holds its Shield AI exposure indirectly, through an interest in a single-asset special purpose vehicle sponsored by an unaffiliated third party that holds Shield AI securities. As of August 20, 2026, the position represented approximately 2.44% of the Fund’s net assets.

Founded in 2015 and headquartered in San Diego, Shield AI builds autonomy software and aircraft for defense applications. The company’s Hivemind AI pilot enables aircraft to operate in environments where GPS and communications links are jammed or denied, and the company has described Hivemind as continuously deployed in real-world operational environments since 2018. In June 2026, the U.S. Air Force awarded Shield AI a production contract to implement Hivemind as mission autonomy software for the Collaborative Combat Aircraft program. The company’s MQ-35 V-BAT, a vertical takeoff and landing unmanned aircraft system requiring no runway or launch infrastructure, has been procured by the U.S. Coast Guard and allied militaries including the Netherlands Ministry of Defence. In March 2026, Shield AI announced a $2 billion raise at a $12.7 billion post-money valuation, led by Advent International with participation from the Strategic Investment Group of JPMorganChase’s Security and Resiliency Initiative and funds managed by Blackstone.

About Defiance ETFs

Defiance ETFs is a leading issuer of thematic, income, and leveraged exchange-traded funds with more than $12 billion in assets under management. Founded in 2018, Defiance has established itself as a first mover in select thematic categories including AI infrastructure, quantum computing, and drone and modern warfare technology. For more information, visit www.defianceetfs.com.

* As of August 7, 2026, based on a review of SEC EDGAR filings, publicly available ETF issuer holdings disclosures, and U.S. and non-U.S. exchange listings, Defiance ETFs has identified no other exchange-traded fund that holds or has held securities of Shield AI, Inc., a privately held defense technology company, and accordingly believes the Defiance Drone & Modern Warfare ETF (NYSE: JEDI) is the first ETF to hold Shield AI.

IMPORTANT DISCLOSURES

Shield AI is not affiliated with, and does not sponsor, endorse, or promote, Defiance ETFs or the Fund. References to Shield AI are not a recommendation to buy or sell any security. Fund holdings are subject to change and should not be considered investment advice.

The Fund’s investment objectives, risks, charges, and expenses must be considered carefully before investing. The prospectus and summary prospectus contain this and other important information about the investment company. Please read carefully before investing. A hard copy of the prospectuses can be requested by calling 833.333.9383.

Defiance ETFs LLC is the Fund’s investment adviser. The Fund’s sub-adviser is Penserra Capital Management LLC.

Investing involves risk. Principal loss is possible. As an ETF, the Fund may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. A portfolio concentrated in a single industry or country may be subject to a higher degree of risk.

Private Company / Privately Offered Securities Risk: Securities of private companies are not traded on an exchange and are typically issued without registration under the Securities Act of 1933. Such investments are subject to significant risks, including illiquidity risk, valuation risk, limited disclosure and lack of certain regulatory protections available to investors in publicly traded securities, exit strategy risk, and the risk of total loss. Private companies may have limited operating histories, unproven business models, and limited access to capital.

Investment Selection Risk (Private Sleeve): The Fund’s investments in privately issued securities are selected by the Adviser in its discretion and are not selected by reference to the Index. Those selection decisions may underperform the Index, other relevant benchmarks, or alternative investments the Adviser could have selected.

Sponsor Dependence Risk: The Fund depends on the SPV sponsor for administration of the SPV, transmission of information rights, the conduct of the SPV’s relationship with the underlying issuer, and implementation of any liquidity event. The SPV sponsor may have interests that diverge from those of the Fund.

Liquidity Risk: The Fund’s SPV interest is not traded on any public market, is not redeemable on demand at the option of the Fund, and may be transferred only with the consent of the SPV sponsor. The Fund’s ability to monetize the investment generally depends on the occurrence of a qualifying liquidity event at the underlying issuer. There is no assurance that any such liquidity event will occur within any particular time frame, on any particular terms, or at all.

Illiquid Investments Risk: The Fund may invest up to 15% of its net assets in illiquid investments. Illiquid investments may be difficult or impossible to sell at the time or price desired, may be sold at a substantial discount to carrying value, and may adversely affect the Fund’s ability to meet redemption requests.

Valuation Risk: Private company securities are fair valued in accordance with procedures adopted pursuant to Rule 2a-5 under the Investment Company Act of 1940. Fair valuations involve subjective judgments, and the value at which an investment is ultimately realized may differ, potentially materially, from the most recent fair value determination.

Premium/Discount Risk: The Fund’s SPV interest does not have an observable market price during the trading day and is reflected in the Fund’s daily net asset value at fair value. As a result, Fund shares may trade at a premium or discount to net asset value to a greater extent, and with greater volatility, than has historically been the case for the Fund.

Tracking Error / Index Divergence Risk: Because the Fund holds an investment that is not a component of the Index, the Fund’s performance is expected to diverge from the performance of the Index. The magnitude of this divergence may be material.

Concentration Risk: A portfolio concentrated in a single industry or country may be subject to a higher degree of risk than a more diversified portfolio.

Foreign Securities Risk: Investments in foreign securities involve certain risks including risk of loss due to foreign currency fluctuations or to political or economic instability. This risk is magnified in emerging markets.

Small/Mid-Cap Risk: Small and mid-cap companies are subject to greater and more unpredictable price changes than securities of large-cap companies.

Aerospace and Defense Companies Risk: Aerospace and defense companies rely heavily on government demand and contracts, making them sensitive to regulation, budget changes, and spending policies that can significantly affect industry performance.

Drone Companies Risk: Drone companies face risks from changing business cycles, rapid technological change, and government regulation, and may have limited product lines or financial resources. Securities of smaller drone companies tend to be more volatile than those of companies that do not rely heavily on technology.

Non-Diversification Risk: The Fund may invest a larger portion of its assets in fewer issuers than a diversified fund, increasing exposure to the risks of individual companies.

New Fund Risk: The Fund is a recently organized investment company with limited operating history, so prospective investors have a limited track record on which to base their investment decisions.

Effective April 30, 2026, the BITA Drone & Modern Warfare Select Index methodology was updated to expand the list of eligible capability areas, change constituent weighting to a liquidity-momentum factor, and permit between-rebalance additions of high-exposure IPOs and companies pivoting to modern warfare technology. Performance shown for periods prior to April 30, 2026 reflects the Index’s prior methodology and may not be representative of results under the current methodology.

The ‘BITA Drone & Modern Warfare Select Index’ is the exclusive property of BITA GmbH. BITA® is a trademark of BITA GmbH and has been licensed for use for certain purposes by Defiance ETFs LLC. Products based on the BITA Drone & Modern Warfare Select Index are not sponsored, endorsed, sold or promoted by BITA GmbH, and BITA GmbH makes no representation regarding the advisability of trading in such product(s). It is not possible to invest directly in an index.

Diversification does not ensure a profit nor protect against loss in a declining market.

Commissions may be charged on trades.

Distributed by Foreside Fund Services, LLC.

Media Contact:

Brenda Hentschel
[email protected]
201.705.3758

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/3b590799-d080-4b21-88c6-63cf8dee0128

https://www.globenewswire.com/NewsRoom/AttachmentNg/e22ba471-96f7-449e-8fb5-7e81cf860dfd

NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, reminds investors that a class action lawsuit has been filed on behalf of persons and entities that sold the common stock of Smartsheet Inc. (NYSE: SMAR) (“Smartsheet” or the “Company”) between June 1, 2024 and September 23, 2024, inclusive (the “Class Period”).

PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION

Investors who sold Smartsheet shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for October 5, 2026.

Smartsheet is a software-as-a-service company that offers a cloud-based work management platform and other professional services.

According to the complaint, on January 24, 2024, Smartsheet received an unsolicited, non-public offer from a consortium comprised of Blackstone Inc. and Vista Equity Partners Management, LLC (the “Consortium”) to purchase all Smartsheet’s outstanding shares for $56.25 per share. In April 2024, Smartsheet’s Board of Directors approved a share repurchase program authorizing the Company to buy back up to $150 million of its outstanding stock. On July 8, 2024, the Consortium raised its offer to $56.50 per share, and on August 21, 2024, it reiterated that
offer.

The complaint further alleges that while these offers remained undisclosed to the investing public, Smartsheet continued to repurchase its common stock on the open market at prices significantly below the Consortium’s offers, denying unsuspecting sellers the benefit of the pending acquisition price.

During the Class Period, Smartsheet’s average stock price was $46.45 per share — well below the Consortium’s offers. On September 24, 2024, before the market opened, Smartsheet publicly disclosed the transaction with the Consortium. The merger closed on January 22, 2025, with the Consortium acquiring Smartsheet for $56.50 per share, a price significantly higher than what any Class Period sellers received on the open market.

WHY WOLF HALDENSTEIN?

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

There is no cost or obligation to speak with an attorney.

Contact:

• Phone: (800) 575-0735 or (212) 545-4774
• Email: 
  [email protected]
• Contact Person: Gregory Stone, Director of Case and Financial Analysis

Firm Website:
Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

NEW YORK and SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a securities class action lawsuit has been filed in the announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) (“Aardvark” or the “Company”):

• common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s Initial Public Offering (the “IPO” or “Offering”) conducted on or about February 13, 2025 and/or
• Aardvark securities between February 13, 2025, and May 14, 2026, both dates inclusive (the “Class Period”).

Investors who purchased Aadvark shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for October 13, 2026.

The filed Complaint alleges that Defendants failed to disclose to investors that:

• ARD-101 was less safe than Defendants had led investors to believe;
• accordingly, ARD-101’s clinical, regulatory, and commercial prospects were
  overstated; and
• as a result, Defendants’ public statements were materially false and misleading at all relevant times.

It is alleged that the truth began to emerge on February 27, 2026, when Aardvark issued a press release “announc[ing] it is voluntarily pausing the Phase 3 Hunger Elimination or Reduction Objective (HERO) trial.” Aardvark attributed the decision to “reversible cardiac observations at above target therapeutic doses found during routine safety monitoring in a healthy volunteer study” and said that it “has voluntarily paused ongoing enrollment and dosing in the HERO trial” while “conducting a comprehensive review of the data to inform next steps.”

On this news, Aardvark’s stock price fell $7.02 per share, or 56.2%, to close at $5.47 per share on March 2, 2026.

WHY WOLF HALDENSTEIN?

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

There is no cost or obligation to speak with an attorney.

Contact:

• Phone: (800) 575-0735 or (212) 545-4774
• Email: 
  [email protected]
• Contact Person: Gregory Stone, Director of Case and Financial Analysis

Firm Website:
 Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SPRINGDALE, Ark., Aug. 24, 2026 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (the “Company” or “we”) (NYSE: TSN) announced today the pricing terms of the previously announced offers by the Company to purchase for cash each series (each, a “Series”) of the notes listed in the table below (the “Notes”) (i) in accordance with, and in the order of, the corresponding Acceptance Priority Levels and (ii) subject to, among other things, the Maximum Tender Cap, the 2027 Tender Sub-Cap and pro rata allocation, upon the terms and subject to the conditions set forth in the Offer to Purchase (as defined below). The Company also announced that it had eliminated the 5.400% 2029 Tender Sub-Cap. The offers to purchase with respect to each Series of Notes are referred to herein as the “Offers” and each, an “Offer.” Each Offer is made upon the terms and subject to the conditions set forth in the offer to purchase, dated August 10, 2026 (as amended or supplemented from time to time, the “Offer to Purchase”). Except as described in this press release, the terms and conditions of the Offers set forth in the Offer to Purchase remain unchanged. Capitalized terms used but not defined in this press release have the meanings given to them in the Offer to Purchase.

The applicable Total Consideration for each $1,000 in principal amount of Notes validly tendered and not validly withdrawn before 5:00 P.M., New York City time, on August 21, 2026 (the “Early Tender Deadline”) and accepted for purchase pursuant to the Offers was determined by reference to the applicable fixed spread for the Notes over the yield based on the bid price of the applicable reference security, as set forth in the table below. The Tender Offer Yield (as determined pursuant to the Offer to Purchase) listed in the table below was determined at 10:00 A.M., New York City time, today, August 24, 2026, by the Dealer Managers (as defined below). The Total Consideration for the Notes includes an early tender premium (the “Early Tender Premium”) of $30.00 per $1,000 principal amount of Notes accepted for purchase.

The following table sets forth the pricing terms for the Offers:

(1) The 2027 Tender Sub-Cap represents the maximum aggregate purchase price of 3.550% Senior Notes due 2027 that will be purchased within the Offers. We reserve the right, but are under no obligation, to increase, decrease or eliminate the 2027 Tender Sub-Cap at any time, subject to compliance with applicable law.

(2) Per $1,000 principal amount of Notes validly tendered and not validly withdrawn and accepted for purchase in the applicable Offer at or prior to the Early Tender Deadline. Excludes Accrued Interest. Includes the Early Tender Premium.

As of the date of this press release, the Financing Condition has been satisfied. We expect settlement for the Notes validly tendered and not validly withdrawn at or prior to the Early Tender Deadline and accepted for purchase to occur on August 26, 2026. All payments for the Notes validly tendered and not validly withdrawn at or prior to the Early Tender Deadline and accepted for purchase will also include accrued and unpaid interest from the last interest payment date up to, but not including, the Early Settlement Date (the “Accrued Interest”). All Notes that have been accepted for purchase will be retired and canceled and will no longer remain outstanding obligations of the Company or any of the Company’s subsidiaries.

The Offers will expire at 5:00 P.M., New York City time, on September 8, 2026 (as the same may be extended with respect to any Offer, the “Expiration Date”). As a result of reaching the previously announced amount of $1,200,000,000 (the “Maximum Tender Cap”), by the Early Tender Deadline, no Notes tendered after the Early Tender Deadline will be accepted for purchase, regardless of their Acceptance Priority Level. Notes not accepted for purchase will be returned promptly to the tendering holders of the Notes (“Holders”) (or, in the case of Notes tendered by book-entry transfer, such Notes will be promptly credited to the account maintained at The Depository Trust Company from which such Notes were delivered) and otherwise returned in accordance with the Offer to Purchase.

BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Rabo Securities USA, Inc. are serving as the Dealer Managers in connection with the Offers (collectively, the “Dealer Managers”). Questions regarding terms and conditions of the Offers should be directed to BofA Securities, Inc. by calling toll free at (888) 292-0070 or collect at (980) 388-0539, to J.P. Morgan Securities LLC by calling toll free at (866) 834-4666 or collect at (212) 834-4818, to Morgan Stanley & Co. LLC by calling toll free at (800) 624-1808 or collect at (212) 761-1057 or to Rabo Securities USA, Inc. by calling toll free at (866) 746-3850.

D.F. King & Co., Inc. has been appointed as information agent and tender agent in connection with the Offers. Questions or requests for assistance in connection with the Offers or the delivery of tender instructions, or for additional copies of the Offer to Purchase, may be directed to D.F. King & Co., Inc. by calling collect at (212) 257-2075 (for banks and brokers) or toll free at (800) 967-5074 (for all others) or via e-mail at [email protected]. You may also contact your broker, dealer, commercial bank, trust company or other nominee for assistance concerning the Offers.

None of the Company, the Dealer Managers, D.F. King & Co., Inc., the trustee under the indenture governing the Notes or any of their respective affiliates is making any recommendation as to whether Holders should tender any Notes in response to the Offers. Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amounts of Notes to tender.

This press release is for informational purposes only and is not an offer to purchase or sell or a solicitation of an offer to purchase or sell with respect to any securities. Neither this press release nor the Offer to Purchase, or the electronic transmission thereof, constitutes an offer to purchase or sell or a solicitation of an offer to purchase or sell with respect to any securities, as applicable, in any jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such offer or solicitation under applicable securities laws or otherwise. The distribution of this press release in certain jurisdictions may be restricted by law. In those jurisdictions where the securities, blue sky or other laws require the Offers to be made by a licensed broker or dealer and the Dealer Managers or any of their respective affiliates is such a licensed broker or dealer in any such jurisdiction, the Offers shall be deemed to be made by the Dealer Managers or such affiliate, as the case may be, on behalf of the Company in such jurisdiction.

About Tyson Foods, Inc.

Tyson Foods, Inc. (NYSE: TSN) is a world-class food company and recognized leader in protein. Founded in 1935 by John W. Tyson, it has grown under four generations of family leadership. The Company is unified by this purpose: Tyson Foods. We Feed the World Like Family™ and has a broad portfolio of iconic products and brands including Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, State Fair®, aidells® and ibp®. Tyson Foods is dedicated to bringing high-quality food to every table in the world, safely and affordably, now and for future generations. Headquartered in Springdale, Arkansas, the Company is a member of the S&P 500 and Russell 1000 large capitalization indices. It had approximately 133,000 team members on September 27, 2025.

Note Regarding Forward-Looking Statements

Certain information in this release constitutes forward-looking statements as contemplated by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, current views and estimates of our outlook for fiscal 2026, other future economic circumstances, industry conditions in domestic and international markets, our performance and financial results (e.g., debt levels, return on invested capital, value-added product growth, capital expenditures, tax rates, access to foreign markets and dividend policy). These forward-looking statements are subject to a number of factors and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements, which are expressly qualified in their entirety by this cautionary statement and speak only as of the date made. Other important factors are discussed in detail in the company’s filings with the Securities and Exchange Commission, including in Part I, Item 1A. “Risk Factors” included in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

MOUNTLAKE TERRACE, Wash., Aug. 24, 2026 (GLOBE NEWSWIRE) — FS Bancorp, Inc. (NASDAQ: FSBW) (“Company”), the holding company for 1st Security Bank of Washington (“Bank”) announced that its Board of Directors has authorized a share repurchase program of up to $5.0 million in shares of the Company’s outstanding common stock in the open market, in privately negotiated transactions from time to time over a 12-month period until August 24, 2027, at such prices as may be determined by the Company’s management. The repurchase program will commence no sooner than the second trading day after the public announcement of this repurchase program.

The repurchase program permits shares to be repurchased in open market or private transactions or pursuant to a trading plan adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission (“SEC”).

Repurchases will be made at management’s discretion at prices management considers to be attractive and in the best interests of both the Company and its shareholders, subject to the availability of stock, general market conditions, the trading price of the stock, alternative uses for capital, and the Company’s financial performance. Open market purchases will be conducted in accordance with the limitations set forth in Rule 10b-18 of the SEC and other applicable legal requirements.

The repurchase program may be suspended, terminated or modified at any time for any reason, including market conditions, the cost of repurchasing shares, the availability of alternative investment opportunities, liquidity, and other factors deemed appropriate. These factors may also affect the timing and amount of share repurchases. The repurchase program does not obligate the Company to purchase any particular number of shares.

About FS Bancorp

FS Bancorp, Inc., a Washington corporation, is the holding company for 1st Security Bank of Washington. The Bank offers a range of loan and deposit services primarily to small- and middle-market businesses and individuals in Washington and Oregon. It operates through 33 bank branches, one headquarters office that provides loans and deposit services, and loan production offices in various suburban communities in the greater Puget Sound area, the Kennewick-Pasco-Richland metropolitan area of Washington, also known as the Tri-Cities, the greater Portland metropolitan area and in Vancouver, Washington. Additionally, the Bank services home mortgage customers across the Northwest, focusing on markets in Washington State including the Puget Sound, Tri-Cities, and Vancouver. Following the acquisition of Pacific West Bank, the Bank expanded its presence in the greater Portland market through locations in West Linn, Lake Oswego, Portland, and Vancouver.

For more information visit 1st Security Bank’s website at www.fsbwa.com.

Forward-Looking Statements

When used in this press release and in other documents filed with or furnished to the Securities and Exchange Commission (the “SEC”), in press releases or other public stockholder communications, or in oral statements made with the approval of an authorized executive officer, the words or phrases “believe,” “will,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” “plans,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts but instead represent management’s current expectations and forecasts regarding future events, many of which are inherently uncertain and outside of our control. Actual results may differ, possibly materially from those currently expected or projected in these forward-looking statements. Factors that could cause the Company’s actual results to differ materially from those described in the forward-looking statements, include but are not limited to, the following: adverse impacts to economic conditions in the Company’s local market areas, other markets where the Company has lending relationships, or other aspects of the Company’s business operations or financial markets, including, without limitation, as a result of employment levels; labor shortages, the effects of inflation, recessionary pressures or slowing economic growth; changes in interest rates and the duration of such changes, including actions by the Federal Reserve, which could adversely affect our revenues and expenses, the values of our assets and obligations, and the availability and cost of capital and liquidity; the impact of inflation and monetary and fiscal policy responses thereto and their impact on consumer and business behavior; geopolitical developments and international conflicts including but not limited to tensions or instability in Eastern Europe, the Middle East, and Asia, or the imposition of new or increased tariffs and trade restrictions, which may disrupt financial markets, global supply chains, energy prices, or economic activity in specific industry sectors; the effects of a federal government shutdown, debt ceiling standoff, or other fiscal policy uncertainty; increased competitive pressures, including repricing and competitors’ pricing initiatives, and their impact on our market position, loan, and deposit products; adverse changes in the securities markets, the Company’s ability to execute its plans to grow its residential construction lending, mortgage banking, and warehouse lending operations, and the geographic expansion of its indirect home improvement lending; challenges arising from expanding into new geographic markets, products, or services; secondary market conditions for loans and the Company’s ability to originate loans for sale and sell loans in the secondary market; volatility in the mortgage industry; fluctuations in deposits; liquidity issues, including our ability to borrow funds or raise additional capital, if necessary; the impact of bank failures or adverse developments at other banks and related negative press about the banking industry in general on investor and depositor sentiment; the ability to adapt to rapid technological changes, including advancements in artificial intelligence, digital banking, and cybersecurity; legislation or regulatory changes, including but not limited to shifts in capital requirements, banking regulation, tax laws, or consumer protection laws; vulnerabilities  in information systems or third-party service providers, including disruptions, breaches, or attacks; environmental, social and governance goals; the effects of climate change, severe weather events, natural disasters, pandemics, epidemics and other public health crises, acts of war or terrorism, domestic political unrest and other external events on our business; and other factors described in the Company’s latest Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other reports filed with or furnished to the SEC which are available on its website at www.fsbwa.com
and on the SEC’s website at www.sec.gov.

Any of the forward-looking statements that the Company makes in this press release and in the other public statements are based upon management’s beliefs and assumptions at the time they are made and may turn out to be incorrect because of the inaccurate assumptions the Company might make, because of the factors illustrated above or because of other factors that cannot be foreseen by the Company. Therefore, these factors should be considered in evaluating the forward-looking statements, and undue reliance should not be placed on such statements. The Company does not undertake and specifically disclaims any obligation to revise any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements. 

Contacts:

Matthew D. Mullet,
President and Chief Executive Officer
Phillip D. Whittington,
Chief Financial Officer

(425) 771-5299
www.FSBWA.com